Balentine LLC’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Balentine LLC’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-559	Closed	-$1K	–	603
2017 Q4	$1K	Hold	559	–	–	﹤0.01%	624
2017 Q3	$2K	Hold	559	–	–	﹤0.01%	618
2017 Q2	$2K	Hold	559	–	–	﹤0.01%	591
2017 Q1	$3K	Hold	559	–	–	﹤0.01%	533
2016 Q4	$3K	Hold	559	–	–	﹤0.01%	472
2016 Q3	$3K	Hold	559	–	–	﹤0.01%	429
2016 Q2	$2K	Hold	559	–	–	﹤0.01%	442
2016 Q1	$2K	Hold	559	–	–	﹤0.01%	319
2015 Q4	$3K	Hold	559	–	–	﹤0.01%	398
2015 Q3	$3K	Hold	559	–	–	﹤0.01%	437
2015 Q2	$5K	Hold	559	–	–	﹤0.01%	355
2015 Q1	$3K	Buy	+559	New	+$1.82K	﹤0.01%	326

Other funds holding SGYP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return